Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Letter - great, but...

"At recent share prices, this initiative gives us $20-25 million in additional share value leverage with which to negotiate."

I asked Investor Relations two times, if these 100mio additional shares mean, that the company is not expecting the same value coming from the MMP licenses, but didn't receive an answer so far.

I would have preferred, if RG had said "this initiative gives us $100-250 million in additional share value at prices we expect for the next months"...lol

GLTA



3
Sep 23, 2008 07:40AM
1
Sep 23, 2008 03:46PM
1
Sep 24, 2008 11:58AM
Share
New Message
Please login to post a reply